Trials / Completed
CompletedNCT02206022
Remifentanil And Local Anesthesia Compared With Local Anesthesia For The Insertion Of Central Venous Catheters
REMIFENTANIL AND LOCAL ANESTHESIA COMPARED WITH LOCAL ANESTHESIA FOR THE INSERTION OF CENTRAL VENOUS CATHETERS IN AWAKE PATIENTS
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
At present, there is no reference protocol for Central Venous Catheter (CVC) insertion assuring analgesia, anxiolysis and safety. Medical teams use various levels of analgesia and anesthesia to realize this gesture, from single local anesthesia to general anesthesia. Remifentanil has been shown to decrease pain scores for insertion and removal of long-term central venous access. Remifentanil is also often employed for pediatric or labor analgesia for short acts as procedural sedation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil | Pain's evaluation for Remifentanil Group |
| DRUG | Placebo | CVC pain's evaluation after local anesthesia + placebo infusion |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2014-08-01
- Last updated
- 2020-07-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02206022. Inclusion in this directory is not an endorsement.